AMZ2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.026200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.921200E-01
Normal-vs-Stage2
2.001400E-01
Normal-vs-Stage3
2.551600E-01
Normal-vs-Stage4
5.149400E-01
Stage1-vs-Stage2
5.983000E-01
Stage1-vs-Stage3
4.444400E-01
Stage1-vs-Stage4
9.946200E-01
Stage2-vs-Stage3
4.956800E-01
Stage2-vs-Stage4
6.709800E-01
Stage3-vs-Stage4
4.906800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.057000E-01
Normal-vs-AfricanAmerican
5.499200E-01
Normal-vs-Asian
1.726400E-01
Caucasian-vs-AfricanAmerican
5.450200E-01
Caucasian-vs-Asian
5.987800E-01
AfricanAmerican-vs-Asian
3.019400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.668800E-01
Normal-vs-Female
3.733200E-01
Male-vs-Female
3.148400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.729000E-01
Normal-vs-Age(41-60Yrs)
6.860200E-01
Normal-vs-Age(61-80Yrs)
1.672020E-01
Normal-vs-Age(81-100Yrs)
2.331400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.897000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.159800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.107000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.264440E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.443800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.651400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.991900E-02
Normal-vs-Daily Drinker
2.747200E-01
Normal-vs-Weekly Drinker
3.058600E-01
Normal-vs-Occasional Drinker
8.598400E-01
Normal-vs-Social Drinker
6.885600E-01
Non Drinker-vs-Daily Drinker
2.825400E-01
Non Drinker-vs-Weekly Drinker
1.960570E-01
Non Drinker-vs-Occasional Drinker
3.113700E-02
Non Drinker-vs-Social Drinker
1.356320E-02
Daily Drinker-vs-Weekly Drinker
8.261600E-01
Daily Drinker-vs-Occasional Drinker
1.593160E-01
Daily Drinker-vs-Social Drinker
2.225600E-01
Weekly Drinker-vs-Occasional Drinker
2.817600E-01
Weekly Drinker-vs-Social Drinker
3.446800E-01
Occasional Drinker-vs-Social Drinker
7.908000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.438200E-01
Normal-vs-Grade 2
9.717400E-01
Normal-vs-Grade 3
9.154600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.271830E-01
Grade 1-vs-Grade 3
4.088600E-01
Grade 1-vs-Grade 4
6.438200E-01
Grade 2-vs-Grade 3
2.486600E-01
Grade 2-vs-Grade 4
9.717400E-01
Grade 3-vs-Grade 4
9.154600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.225020E-01
Normal-vs-NonDiabetic
3.627000E-01
Diabetic-vs-NonDiabetic
1.250420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.543200E-01
Normal-vs-NoPancreatitis
2.680600E-01
Pancreatitis-vs-NoPancreatitis
9.340600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.855600E-01
Normal-vs-N1
2.029600E-01
N0-vs-N1
1.840630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.653200E-01
Normal-vs-TP53-NonMutant
5.544400E-01
TP53-Mutant-vs-TP53-NonMutant
5.143000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
